Table 4

LIVE Score stability and mortality

Alive in year 1
N (%)
Mortality
year 1 to year 4
N (%)
Survived
year 1 to year 4
N (%)
Stability (same LIVE Score year 1 to year 4) N (%)P value
(test of proportions)
Total for all health systems categorised LIVE Score (high-risk, medium-risk and low risk)
Year 1 LIVE Risk Score
 High-risk LIVE4330 (3.9%)1985 (45.8%)2345 (54.2%)207 (8.8%)High vs medium, stability, p<0.001
 Medium-risk LIVE16 732 (15.2%)4160 (24.9%)12 572 (75.1%)6049 (48.1%)Medium vs low, stability, p<0.001
 Low-risk LIVE89 377 (80.9%)5528 (6.2%)83 849 (93.8%)66 245 (79.0%)Low vs high, stability, p<0.001
 Total110 439 (100%)11 673 (10.6%)98 766 (89.4%)72 501 (73.4%)All groups trend test for stability, p<0.001
Total for all health systems LIVE Score 1 through 5
Year 1 LIVE Score
 LIVE 11361 (1.2%)744 (54.7%)617 (45.3%)45 (7.3%)1 vs 2, stability p=0.14
 LIVE 22969 (2.7%)1241 (41.8%)1728 (58.2%)162 (9.4%)2 vs 3, stability p<0.001
 LIVE 316 732 (15.2%)4160 (24.9%)12 572 (75.1%)6049 (48.1%)3 vs 4, stability, p<0.001
 LIVE 433 633 (30.5%)3397 (10.1%)30 236 (89.9%)21 130 (69.9%)4 vs 5, stability, p<0.001
 LIVE 555 744 (50.5%)2131 (3.8%)53 613 (96.2%)45 115 (84.1%)5 vs 1, stability, p<0.001
 Total110 439 (100%)11 673 (10.6%)98 766 (89.4%)72 501 (73.4%)All groups trend test for stability, p<0.001
  • LIVE Score stability and mortality for all health systems is summarised. High-risk LIVE Score patients, only 54.5% of whom were alive at 4 years, were unlikely to remain high risk (only 8.8% of survivors remained with a high-risk LIVE Score). Thus the high-risk LIVE Score was unstable. In contrast, low-risk LIVE Score patients, the majority of whom were alive after 4 years (89.4%), were very likely to remain low risk. The low-risk LIVE Score was stable, with 73.4% of patients remaining low risk at 4 years. Similar patterns were noted when the LIVE Score was broken out into the five categories of lowest (LIVE 5) to highest (LIVE 1) risk with number of survivors and stability increasing with decreasing mortality risk.

  • LIVE, Laboratory-based Intermountain Validated Exacerbation.